LOS ANGELES--(BUSINESS WIRE)--In classic Las Vegas fashion, with red-feathered showgirls and an Elvis
impersonator entertaining the crowds, MedMen
Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQB:
MMNFF) opened its first branded store in the tourist mecca and
entertainment capital of the world.

Located at 823 3rd Street in the Arts District and near the
Fremont Street Experience, MedMen Downtown Las Vegas is the Company’s 14th
store nationwide. MedMen has been operating a second dispensary in North
Las Vegas, which won approval last month to move to 4503 Paradise Road
near the Hard Rock Hotel, the Thomas and Mack Center and McCarran
International Airport. MedMen Las Vegas Airport is currently under
construction.

“We’re excited to put an anchor here in Downtown Las Vegas. Nevada is
setting an example for the world,” said MedMen CEO Adam Bierman during a
ribbon-cutting ceremony attended by local dignitaries and a crowd of
onlookers awaiting to enter the store. “This is just the beginning.”

Nevada State Senator Tick Segerblom, a longtime advocate for marijuana
legalization, was in attendance. “We are so excited to have MedMen here
in Downtown Las Vegas,” said Segerblom. “They are the premiere brand in
the world and we can’t thank them enough for coming here.”

Las Vegas City Councilwoman Michele Fiore said, “MedMen is raising the
bar. This is not a pot shop. This is a retail store that shatters
stereotypes. This is the future of cannabis.”

Nevada also is one of the fastest growing state-sanctioned marijuana
markets in the country. According
to the Nevada Department of Taxation, cannabis accounted for about
$386 million of the total statewide taxable sales for the period of July
2017 through March 2018, about 19.3 percent of the state’s growth in
taxable sales compared to the same period last year.

A leading cultivator, producer and retailer of state-sanctioned cannabis
in the U.S., MedMen currently operates licensed facilities in
California, Nevada and New York.

ABOUT MEDMEN:

MedMen Enterprises is the preeminent cannabis company in the U.S. with
assets and operations nationwide. Based in Los Angeles, MedMen brings
expertise and capital to the cannabis industry and is one of the
nation’s largest financial supporters of progressive marijuana laws.
Visit http://www.medmen.com

Source: MedMen Enterprises

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information”
within the meaning of applicable Canadian securities legislation and may
also contain statements that may constitute “forward-looking statements”
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only MedMen’s beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of MedMen’s control. Generally, such forward-looking information
or forward-looking statements can be identified by the use of
forward-looking terminology such as “plans”, “expects” or “does not
expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”,
“intends”, “anticipates” or “does not anticipate”, or “believes”, or
variations of such words and phrases or may contain statements that
certain actions, events or results “may”, “could”, “would”, “might” or
“will be taken”, “will continue”, “will occur” or “will be achieved”.
The forward-looking information and forward-looking statements contained
herein may include, but is not limited to, information concerning the
timing of the opening of new stores in Las Vegas and plans for
additional stores in Las Vegas.

By identifying such information and statements in this manner, MedMen
is alerting the reader that such information and statements are subject
to known and unknown risks, uncertainties and other factors that may
cause the actual results, level of activity, performance or achievements
of MedMen to be materially different from those expressed or implied by
such information and statements. In addition, in connection with the
forward-looking information and forward-looking statements contained in
this press release, MedMen has made certain assumptions. Among the key
factors that could cause actual results to differ materially from those
projected in the forward-looking information and statements are the
following: adverse changes in the public perception of cannabis; changes
in consumer demand for cannabis; decreases in the prevailing prices for
cannabis and cannabis products in the markets in which the Company
operates; adverse changes in applicable laws; adverse changes in the
application or enforcement of current laws, including those related to
taxation; increasing costs of compliance with extensive government
regulation; changes in general economic, business and political
conditions, including changes in the financial markets and in particular
in the ability of the Company to raise debt and equity capital in the
amounts and at the costs that it expects; risks related to licensing,
including the ability to obtain the requisite licenses or renew existing
licenses for the Company’s proposed operations; dependence upon third
party service providers skilled labor and key inputs for purposes for
example facility design and construction activities; risks inherent in
the agricultural business; intellectual property risks; risks related to
litigation; dependence upon senior management. Should one or more of
these risks, uncertainties or other factors materialize, or should
assumptions underlying the forward-looking information or statements
prove incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or
expected.

Although MedMen believes that the assumptions and factors used in
preparing, and the expectations contained in, the forward-looking
information and statements are reasonable, undue reliance should not be
placed on such information and statements, and no assurance or guarantee
can be given that such forward-looking information and statements will
prove to be accurate, as actual results and future events could differ
materially from those anticipated in such information and statements.
The forward-looking information and forward-looking statements contained
in this press release are made as of the date of this press release, and
MedMen does not undertake to update any forward-looking information
and/or forward-looking statements that are contained or referenced
herein, except in accordance with applicable securities laws. All
subsequent written and oral forward-looking information and statements
attributable to MedMen or persons acting on its behalf is expressly
qualified in its entirety by this notice.